Abiopharma

🔍 Van Oene Mark (Executive)

Company: PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)

Report Date: 2026-08-10

Detailed Transactions and Holdings:

• Acquired 489,130 shares of Common Stock (Direct)
  Date: 2026-08-10 | Code: A | equity_swap_involved: 0 | shares_owned_after: 2,732,764.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 1,967,888 shares of Stock Option (right to buy) at $1.15 per share (Derivative)
  Date: 2026-08-10 | Code: A | Expires: 2036-08-10 | equity_swap_involved: 0 | shares_owned_after: 1,967,888.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest in equal annual installments on August 10 of each of 2027, 2028, and 2029, subject to the Reporting Person's continued status as a service provider through the applicable vesting dates.
• F2: The shares subject to the option will vest in 36 equal monthly installments beginning on September 10, 2026, subject to the Reporting Person's continued status as a service provider through the applicable vesting dates.
• REMARKS: President & CEO